Immediate Impact
82 standout
Citing Papers
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
2024 Standout
Works of G. Kurteva being referenced
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVE
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| G. Kurteva | 673 | 663 | 245 | 25 | 1.0k | |
| Constantin Volovăț | 755 | 640 | 265 | 43 | 1.3k | |
| Jian Wu | 564 | 746 | 283 | 29 | 1.3k | |
| André M. Murad | 732 | 929 | 368 | 21 | 1.1k | |
| Claire Saffery | 555 | 614 | 325 | 17 | 860 | |
| Kazuhiko Yonekura | 761 | 617 | 291 | 23 | 1.3k | |
| Hideyuki Ohshimo | 993 | 704 | 315 | 17 | 1.4k | |
| Isam Eltoum | 522 | 497 | 439 | 26 | 1.2k | |
| Luca Turati | 824 | 418 | 467 | 18 | 1.1k | |
| Yu-Hong Li | 599 | 385 | 281 | 19 | 900 | |
| M. Lichinitser | 659 | 389 | 607 | 24 | 1.3k |
All Works
Loading papers...